Kathy Theall, MD

Kathy Theall, MD has extensive experience in the field of medicine and clinical development. Kathy currently serves as the Vice President of Clinical Development for Breast Cancer at Stemline Therapeutics. Prior to this, they held positions at Pfizer, starting as a Director of Oncology Clinical Development in 2014 and then advancing to the role of Senior Director, Breast Franchise, Global Product Development. Before Pfizer, Kathy worked at PAREXEL as a Medical Director Oncology, where they supported business development and acted as the Global Medical Monitor for various clinical trials in breast and gastrointestinal cancers. Kathy also has experience in medical oncology, having worked at Tufts Medical Center and as an Assistant Professor of Medicine at both Tufts University School of Medicine and Brown University School of Medicine. Kathy began their career as an Oncology Fellow at Beth Israel Deaconess Medical Center and conducted research at Tufts University Department of Physiology. Kathy has a strong background in oncology and has contributed significantly to the field throughout their career.

Kathy Theall, MD began their education at Colegio Santa Fransisca Romana, although the specific years are not provided. Following this, they attended Escuela Colombiana de Medicina-Univesidad El Bosque from 1983 to 1989, where they obtained their Medical Doctor degree. Kathy went on to study at St. Vincent's Hospital from 1992 to 1995, although the specific field of study or degree obtained during this time is not specified.